Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma

Leuk Lymphoma. 2021 Apr;62(4):1003-1006. doi: 10.1080/10428194.2020.1852474. Epub 2020 Dec 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunotherapy, Adoptive
  • Incidence
  • Lymphoma, B-Cell*
  • Multiple Myeloma* / epidemiology
  • Multiple Myeloma* / therapy
  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen* / genetics
  • T-Lymphocytes
  • Venous Thrombosis*

Substances

  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen